EUVIMEDEUVIMED entdecken
Crossref

Salvia officinalis-mediated glycemic amelioration: a phytopharmacological perspective in diabetes management

Hesham N. Mustafa, Gannah H.N. Mustafa, Hana H.N. Mustafa, Gehan A. Hegazy

European Journal of Anatomy · 2026-11 · 30 (6) · 699-707

DOI: 10.52083/jwxh8444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Anatomy, 2026-11. Verfasst von Hesham N. Mustafa und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salvia officinalis (Lamiaceae), commonly known as garden sage, is an evergreen perennial subshrub native to the Mediterranean and now distributed widely across the globe, with a long ethnobotanical record of medicinal use. This study characterized the bioactive phytochemical profile of an ethanolic extract prepared from the leaves and flowers of S. officinalis, and assessed its capacity to ameliorate experimental hyperglycemia in alloxan-treated rats. In an acute dose-ranging experiment, hyperglycemic animals received a single oral dose of the extract (100, 200, 300, 400, 500, or 600 mg/kg), with circulating glucose monitored over 8 h. A subsequent 36-day trial used four groups (n = 8): euglycemic untreated controls, hyperglycemic untreated controls, hyperglycemic rats given 300 mg/kg/day extract, and hyperglycemic rats given metformin (50 mg/kg/day). Serum glucose, insulin, and dipeptidyl peptidase-4 (DPP-4) were quantified on treatment days 1, 18, and 36. Chemical screening identified flavonoids, tannins, triterpenes, and saponins, with no detectable alkaloids. The 300 mg/kg dose produced peak fasting blood glucose (FBG) suppression (81.39% at 8 h). After 36 days of dosing, extract-treated animals showed markedly lower FBG (129.10 ± 14.49 mg/dL) and reduced DPP-4, together with a significant rise in serum insulin, relative to untreated hyperglycemic controls. These findings indicate that the ethanolic extract of S. officinalis possesses meaningful antidiabetic activity in this model, most plausibly through radical-scavenging cytoprotection of insulin-secreting beta cells and inhibition of DPP-4.

Zitieren

APA

Mustafa, H. N., Mustafa, G. H., Mustafa, H. H., & Hegazy, G. A. (2026). Salvia officinalis-mediated glycemic amelioration: a phytopharmacological perspective in diabetes management. European Journal of Anatomy, 30(6), 699-707. https://doi.org/10.52083/jwxh8444

Vancouver

Mustafa HN, Mustafa GH, Mustafa HH, Hegazy GA. Salvia officinalis-mediated glycemic amelioration: a phytopharmacological perspective in diabetes management. European Journal of Anatomy. 2026;30(6):699-707. doi:10.52083/jwxh8444

BibTeX
@article{Mustafa2026,
  author = {Mustafa, Hesham N. and Mustafa, Gannah H.N. and Mustafa, Hana H.N. and Hegazy, Gehan A.},
  title = {Salvia officinalis-mediated glycemic amelioration: a phytopharmacological perspective in diabetes management},
  journal = {European Journal of Anatomy},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {699--707},
  doi = {10.52083/jwxh8444}
}
Kostenlos starten →